Cerus reported $19.53M in Selling and Administration Expenses for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Selling And Administration Expenses Change
Atrion ATRI:US 8.25M 238K
Cerulean Pharma CERU:US $ 2.59M 168.34K
Cerus CERS:US $ 19.53M 1.2M
Cytori Therapeutics CYTX:US $ 2.29M 148K
Haemonetics HAE:US $ 93.17M 7.62M
Meridian Bioscience VIVO:US $ 21.33M 4.74M
Nuvasive NUVA:US $ 160.7M 415K
Orasure Technologies OSUR:US $ 29.26M 2.61M
Sientra SIEN:US 25.72M 75K
Staar Surgical STAA:US $ 38.22M 9.01M
Terumo 4543:JP 70.63B 3.47B